The new executive director has provided this
FREE nonmember REGISTRATION
Using Promotional Code “ExDirComp”
LAVA Bio’s September 29th panel discussion will include a range of professionals in the life science space spanning from real estate, pharma, and strategic partners of the growing LA life science ecosystem. CBRE’s Ian Anderson, Senior Director of Research and Analysis, will kick things off with a high level national overview of the life science market. You’ll hear from the CBRE Los Angeles Life Science Practice Group that has advised Kite Pharma, Kronos Bio, Allogene Therapeutics and more as they’ve grow their lab and office footprints from startup to IPO. You’ll hear from the Co-Founder of HATCHspaces who is investing millions into building and providing wet lab to help support growing companies along with the CEO of BioScience LA who has been supporting the ecosystem for years and recently opened BioScience LA’s new headquarters in Culver City. The discussion will start off with structure and focus and work its way into an informal, fun and open discussion.
- Andrew Riley, Senior Vice President, CBRE
- Jeff Pion, Vice Chairman, CBRE
- Ian Anderson, Senior Director of Research and Analysis, CBRE
- Brian Varnum, P.hD., CEO, Armata Pharmaceuticals
- Allan Glass, Co-Founder and CEO, HATCHspaces
- David Whelan, CEO, BioScience LA
12:00pm - 12:30pm pre panel networking in outside courtyard (IRL only)
1:30pm - 2:00pm post panel campus sneak peak tour (IRL only)
This will be LAVA's first experiment at a hybrid event. We are excited to see those of you joining us in person. We hope you will be patient as we work through any new procedures and policies of the in-person portion of the event. We will require proof of vaccination or a recent negative covid test within 72 hours to participate IRL. Regardless, if you have any symptoms of concern please participate online. Masks will be required for the inside portion of the program but optional outside and in the courtyard.